Get an alert when ANDERSONBRECON (UK) LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2027-03-31 (in 10mo)

Last filed for 2025-06-30

Confirmation statement due

2027-03-01 (in 10mo)

Last made up 2026-02-15

Watchouts

None on the register

Cash

£3K

-88.9% vs 2024

Net assets

£67M

+5.8% vs 2024

Employees

325

-2.7% vs 2024

Profit before tax

£5M

-16.9% vs 2024

Name history

Renamed 2 times since incorporation

  1. ANDERSONBRECON (UK) LIMITED 2012-06-01 → present
  2. BRECON PHARMACEUTICALS LIMITED 1991-07-05 → 2012-06-01
  3. MAPLELOCK LIMITED 1990-09-27 → 1991-07-05

Accounts

2-year trend · latest reflected 2025-06-30

Metric Trend 2024-06-302025-06-30
Turnover £37,463,000£40,186,000
Operating profit £6,365,000£5,291,000
Profit before tax £6,365,000£5,291,000
Net profit £5,056,000£3,656,000
Cash £27,000£3,000
Total assets less current liabilities £63,779,000£67,326,000
Net assets £63,003,000£66,659,000
Equity £63,003,000£66,659,000
Average employees 334325
Wages £13,055,000£13,248,000

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2024-06-302025-06-30
Operating margin 17.0%13.2%
Net margin 13.5%9.1%
Return on capital employed 10.0%7.9%
Gearing (liabilities / total assets) 21.0%18.5%
Current ratio 4.45x5.10x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Standalone (parent only)
Auditor
PricewaterhouseCoopers LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“After making reasonable enquiries and assessing forecasts (up to 31 December 2026) including severe, but plausible and downside scenarios, the directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. This assessment takes into account the recent change in ownership, as detailed in Note 21, which has not adversely affected the group's or the company's financing and / or going concern status. The Group and its subsidiaries (which includes AndersonBrecon (UK) Limited) has financing and facilities which includes a $400M revolving line of credit which is not forecast to be utilised and is part of the available liquidity should the company or group need it. The Group has also provided a letter of support to the company and confirmed its intentions to provide financial support as is necessary for a period of at least 12 months from the date of signing these financial statements.”

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

4 active · 38 resigned

Name Role Appointed Born Nationality
CSC CLS (UK) LIMITED Corporate Secretary 2025-09-04
DE WEERDT, Tom Wim Frans Director 2021-03-10 May 1972 American
HAFFAR, Salim Director 2018-09-20 Apr 1973 American
METZINGER, Jeannie Director 2021-05-17 May 1957 American
Show 38 resigned officers
Name Role Appointed Resigned
BURFORD, Bruce Warren Secretary 1999-07-01 2001-11-30
ROBERTS, Peter Secretary 2001-12-01 2006-03-01
WHITTALL, Julia Rachel Secretary 1999-07-01
CAPITAL LAW AND PEOPLE LIMITED Corporate Secretary 2015-09-14 2025-09-04
REED SMITH CORPORATE SERVICES LIMITED Corporate Secretary 2006-02-28 2013-05-31
REED SMITH CORPORATE SERVICES LIMITED Corporate Secretary 2006-02-28 2015-08-07
BATH, John Roche Director 2006-12-08 2008-04-23
BATH, John Roche Director 2001-12-01 2006-03-01
BELDEN, Peter Schick Director 2009-07-28 2013-05-10
BILLINGTON, Andrew Charles Director 1993-01-01 2006-03-01
BLACK, Alan Angus Director 1999-12-31
BLUMENFELD, Mitchell Eric Director 2016-07-01 2018-06-01
BURFORD, Bruce Warren Director 2001-11-30
CHOU, John Gardner Director 2007-09-14 2013-05-10
COLLIS, Steven Howard Director 2011-07-01 2013-05-10
CUMMINS, Phillip Director 2013-10-18 2016-07-01
DICANDILO, Michael Dennis Director 2006-03-01 2012-03-30
DUPUIS, Serge Director 2019-06-26 2021-03-10
EVERY, Nathan Robert Director 2013-05-10 2016-07-01
FRAZIER, Alan David Director 2013-05-10 2016-07-01
HAUSER, Remy Director 2016-07-01 2020-11-30
HILZINGER, Kurt John Director 2006-03-01 2007-09-14
HOLTON, Peter Stuart Director 2000-10-06 2001-11-28
JOHN, Sujit Director 2016-07-01 2020-11-30
KEMP, Stephen Leonard Director 2001-09-25 2006-03-01
MAYS, Veronica Dorothy Director 1992-07-01 1995-07-01
MILES, Susan Ann Carey, Dr Director 2004-10-01 2006-03-01
MITCHELL, III, William T Director 2013-05-10 2019-06-26
MORELLI, Leon Kenneth Director 2006-03-01
PARKER, Michael John Director 2006-03-01
ROBERTS, Peter Director 1999-07-01 2006-03-01
SCOTT, Gordon Director 1999-07-01 2001-11-30
SCOTT-WYNN, Louise Mary, Dr Director 1999-10-01 2000-10-20
THOMAS, James E Director 2013-10-18 2014-10-21
WHATMORE, William Stephen L Director 2013-10-18 2016-01-06
WHITTERS, Joseph Edward Director 2013-05-10 2016-07-01
YAMADA, Tachi Director 2016-01-06 2016-07-01
YOST, Robert David Director 2006-03-01 2011-07-01

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Pci Penn Uk Holdco Limited Corporate entity Shares 25–50%, Voting 25–50% 2018-02-28 Active
Penn Pharma Group Limited Corporate entity Shares 25–50%, Voting 25–50% 2017-03-17 Active
Brecon Pharmaceuticals Holdings Limited Corporate entity Shares 75–100%, Voting 75–100% 2016-04-06 Ceased 2017-03-17

Filing timeline

Last 20 of 236 total filings

Date Type Category Description
2026-04-19 AA accounts Accounts with accounts type full
2026-04-08 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-10-13 TM02 officers Termination secretary company with name termination date PDF
2025-10-13 AP04 officers Appoint corporate secretary company with name date PDF
2025-04-03 AA accounts Accounts with accounts type full
2025-02-18 CS01 confirmation-statement Confirmation statement with updates PDF
2025-02-18 CH01 officers Change person director company with change date PDF
2025-02-18 CH01 officers Change person director company with change date PDF
2025-01-23 MR01 mortgage Mortgage create with deed with charge number charge creation date PDF
2024-07-25 CH01 officers Change person director company with change date PDF
2024-04-22 CH01 officers Change person director company with change date PDF
2024-03-13 AA accounts Accounts with accounts type full
2024-02-23 CS01 confirmation-statement Confirmation statement with updates PDF
2023-03-08 AA accounts Accounts with accounts type full
2023-02-22 CS01 confirmation-statement Confirmation statement with updates PDF
2022-07-14 CH01 officers Change person director company with change date PDF
2022-07-14 CH01 officers Change person director company with change date PDF
2022-07-14 CH01 officers Change person director company with change date PDF
2022-07-07 AA accounts Accounts with accounts type full
2022-02-22 CS01 confirmation-statement Confirmation statement with updates PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
4

last 12 months

Capital events
0

last 24 months

Officers appointed
1

last 12 months

Officers resigned
1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2024 → FY2025 · period ending 2025-06-30 vs 2024-06-30

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page